Spillovers and Other Externalities in Pharmaceutical Marketing - Innovation and Marketing in the Pharmaceutical Industry - page 679

Table 23.2 Descriptive statistics on monthly time series variables

US Canad a

Variable N Minimum Maximum Mean Std. dev. N Minimum Maximum Mean Std. dev.

Rx scripts
(number)

66 1,670,000.00 3,359,000.00 2,426,909.09 387,575.49 66 161,131.00 303,138.00 230,001.50 34,142.22

Share- weighted
price ($)

66 31.12 40.97 37.89 1.47 66 17.77 21.34 19.46 0.99

Detailing
expend ($)

66 5,102,000 14,283,000 8,736,000 2,265,000 66 77,000 1,064,200 590,800 284,300

OME expend ($) 66 236,700 4,198,600 1,960,600 1,099,900 66 0.00 168,120 58,180 38,970

TV DTCA
expend ($)

66 0.00 19,703,000 4,745,000 4,757,000

Mags DTCA
expend ($)

66 0.00 4,689,000 1,646,800 1,446,200

Note : Information about price, detailing, OME, and DTCA have been adjusted for inlation (with 1992 as the base year) and are reported in US$ for both coun-
tries. The reported analysis combines the TV and magazine DTCA expenditures